In contrast, other CRC studies have shown that high vs. low BECN1 expression is associated with a poorer prognosis and shorter survival in patients treated with surgery alone, and high vs. low BECN1 expression is associated with longer survival in patients after surgical removal of the tumor also undergoing chemotherapy based on 5-FU [52,53]. Here, BECN1 is linked to colorectal carcinoma.